得益于局域表面等離子體共振現象，金納米顆粒具有優良的光學性質，一方面增強了納米金周邊的電磁場，產生強烈的亮點，可應用于成像，另一方面將入射能量轉化為熱量，提高近金納米周邊的局部溫度，可以應用于光熱治療來輔助發射治療，尤其是深表腫瘤的治療。同時金納米顆粒具有較好的生物相容性、較低的生物毒性以及表面吸附載帶能力，可以修飾目標分子、藥物分子及成像造影劑等功能分子，功能化的金納米顆粒在細胞誘導、藥物載體、治療方法、臨床診斷及抗體標記等方面均有應用。
DiagNano? 金納米球系列產品采用球形金納米顆粒生產工藝技術制備而成，尺寸均勻，粒徑分布范圍狹窄，分散性好，無凝聚。金納米球粒徑從20 nm增大至100 nm其表面等離子體共振吸收峰從520 nm紅移至570 nm，吸收峰較窄，粒徑100 nm以上的金納米顆粒，則具有寬光譜吸收。
Size dependence of the surface plasmon resonance of gold nanoparticles
技術參數：
粒徑范圍：10-400 nm
均一度：CV%<12%
具有高度的穩定性，可均勻分散而無沉降
緩沖液：DI water/0.01M PBS (pH 7.4)
儲存條件：避光， 4°C 保存，切勿冷凍
Basic Gold Nanoparticles
| Cat# | Diameter (nm) | Ligand | Optical Density (A.U) | Absorption Max (nm) | NPs/mL | Unit Size |
| BG-5 | 5 | Tannic acid | 1 OD | 515-520 | 5.47E+13 | 20, 100, 500, 1000 mL |
| BG-10 | 10 | Tannic acid | 1 OD | 520 | 5.98E+12 | 20, 100, 500, 1000 mL |
| BG-15 | 15 | Citric acid | 1 OD | 520 | 1.64E+12 | 20, 100, 500, 1000 mL |
| BG-20 | 20 | Citric acid | 1 OD | 524 | 6.54E+11 | 20, 100, 500, 1000 mL |
| BG-30 | 30 | Citric acid | 1 OD | 526 | 1.79E+11 | 20, 100, 500, 1000 mL |
| BG-40 | 40 | Citric acid | 1 OD | 530 | 7.15E+10 | 20, 100, 500, 1000 mL |
| BG-50 | 50 | Citric acid | 1 OD | 535 | 3.51E+10 | 20, 100, 500, 1000 mL |
| BG-60 | 60 | Citric acid | 1 OD | 540 | 1.96E+10 | 20, 100, 500, 1000 mL |
| BG-70 | 70 | Citric acid | 1 OD | 548 | 1.2E+10 | 20, 100, 500, 1000 mL |
| BG-80 | 80 | Citric acid | 1 OD | 553 | 7.82E+9 | 20, 100, 500, 1000 mL |
| BG-90 | 90 | Citric acid | 1 OD | 564 | 5.37E+9 | 20, 100, 500, 1000 mL |
| BG-100 | 100 | Citric acid | 1 OD | 572 | 3.84E+8 | 20, 100, 500, 1000 mL |
| BG-150 | 150 | Citric acid | 1 OD | N/A | 3.6E+8 | 20, 100, 500, 1000 mL |
| BG-200 | 200 | Citric acid | 1 OD | N/A | 1.91E+8 | 20, 100, 500, 1000 mL |
| BG-250 | 250 | Citric acid | 1 OD | N/A | 7.08E+8 | 20, 100, 500, 1000 mL |
| BG-300 | 300 | Citric acid | 1 OD | N/A | 4.50E+8 | 20, 100, 500, 1000 mL |
| BG-400 | 400 | Citric acid | 1 OD | N/A | 1.88E+8 | 20, 100, 500, 1000 mL |
Protein A/G Gold Nanoparticles
| Cat# | Diameter (nm) | Ligand | Optical Density (A.U) | Absorption Max (nm) | NPs/mL | Unit Size |
| GCA-5 | 5 | Protein A | 3 OD | 515-520 | 1.64E+14 | 0.5, 1 mL |
| GCA-10 | 10 | Protein A | 3 OD | 515-520 | 1.79E+13 | 0.5, 1 mL |
| GCA-15 | 15 | Protein A | 3 OD | 520 | 4.92E+12 | 0.5, 1 mL |
| GCA-20 | 20 | Protein A | 3 OD | 524 | 1.96E+12 | 0.5, 1 mL |
| GCA-30 | 30 | Protein A | 3 OD | 526 | 5.37E+11 | 0.5, 1 mL |
| GCA-40 | 40 | Protein A | 3 OD | 530 | 2.14E+11 | 0.5, 1 mL |
| GCA-50 | 50 | Protein A | 3 OD | 535 | 1.05E+11 | 0.5, 1 mL |
| GCA-60 | 60 | Protein A | 3 OD | 540 | 5.88E+10 | 0.5, 1 mL |
| GCA-80 | 80 | Protein A | 3 OD | 553 | 2.35E+10 | 0.5, 1 mL |
| GCA-100 | 100 | Protein A | 3 OD | 572 | 1.15E+10 | 0.5, 1 mL |
| GCG-5 | 5 | Protein G | 3 OD | 515-520 | 1.64E+14 | 0.5, 1 mL |
| GCG-10 | 10 | Protein G | 3 OD | 515-520 | 1.79E+13 | 0.5, 1 mL |
| GCG-15 | 15 | Protein G | 3 OD | 520 | 4.92E+12 | 0.5, 1 mL |
| GCG-20 | 20 | Protein G | 3 OD | 524 | 1.96E+12 | 0.5, 1 mL |
| GCG-30 | 30 | Protein G | 3 OD | 526 | 5.37E+11 | 0.5, 1 mL |
| GCG-40 | 40 | Protein G | 3 OD | 530 | 2.14E+11 | 0.5, 1 mL |
| GCG-50 | 50 | Protein G | 3 OD | 535 | 1.05E+11 | 0.5, 1 mL |
| GCG-60 | 60 | Protein G | 3 OD | 540 | 5.88E+10 | 0.5, 1 mL |
| GCG-80 | 80 | Protein G | 3 OD | 553 | 2.35E+10 | 0.5, 1 mL |
| GCG-100 | 100 | Protein G | 3 OD | 572 | 1.15E+10 | 0.5, 1 mL |
Streptavidin Gold Nanoparticles
| Cat# | Diameter (nm) | Ligand | Optical Density (A.U) | Absorption Max (nm) | NPs/mL | Unit Size |
| GCS-5 | 5 | Streptavidin | 3 OD | 515-520 | 1.64E+14 | 0.5, 1 mL |
| GCS-10 | 10 | Streptavidin | 3 OD | 515-520 | 1.79E+13 | 0.5, 1 mL |
| GCS-15 | 15 | Streptavidin | 3 OD | 520 | 4.92E+12 | 0.5, 1 mL |
| GCS-20 | 20 | Streptavidin | 3 OD | 524 | 1.96E+12 | 0.5, 1 mL |
| GCS-30 | 30 | Streptavidin | 3 OD | 526 | 5.37E+11 | 0.5, 1 mL |
| GCS-40 | 40 | Streptavidin | 3 OD | 530 | 2.14E+11 | 0.5, 1 mL |
| GCS-50 | 50 | Streptavidin | 3 OD | 535 | 1.05E+11 | 0.5, 1 mL |
| GCS-60 | 60 | Streptavidin | 3 OD | 540 | 5.88E+10 | 0.5, 1 mL |
| GCS-80 | 80 | Streptavidin | 3 OD | 553 | 2.35E+10 | 0.5, 1 mL |
| GCS-100 | 100 | Streptavidin | 3 OD | 572 | 1.15E+10 | 0.5, 1 mL |
Biotin Gold Nanoparticles
| Cat# | Diameter (nm) | Ligand | Optical Density (A.U) | Absorption Max (nm) | NPs/mL | Unit Size |
| GFB-5 | 5 | Biotin | 50 OD | 515-520 | 2.73E+15 | 0.5, 1 mL |
| GFB-10 | 10 | Biotin | 50 OD | 520 | 2.99E+14 | 0.5, 1 mL |
| GFB-15 | 15 | Biotin | 50 OD | 520 | 8.19E+13 | 0.5, 1 mL |
| GFB-20 | 20 | Biotin | 50 OD | 524 | 3.27E+13 | 0.5, 1 mL |
| GFB-30 | 30 | Biotin | 50 OD | 526 | 8.96E+12 | 0.5, 1 mL |
| GFB-40 | 40 | Biotin | 50 OD | 530 | 3.58E+12 | 0.5, 1 mL |
| GFB-50 | 50 | Biotin | 50 OD | 535 | 1.76E+12 | 0.5, 1 mL |
| GFB-60 | 60 | Biotin | 50 OD | 540 | 9.8E+11 | 0.5, 1 mL |
| GFB-70 | 70 | Biotin | 50 OD | 548 | 6.0E+11 | 0.5, 1 mL |
| GFB-80 | 80 | Biotin | 50 OD | 553 | 3.91E+11 | 0.5, 1 mL |
| GFB-90 | 90 | Biotin | 50 OD | 564 | 2.69E+11 | 0.5, 1 mL |
| GFB-100 | 100 | Biotin | 50 OD | 572 | 1.92E+11 | 0.5, 1 mL |
Carboxyl-PEG Linker Gold Nanoparticles
| Cat# | Diameter (nm) | Ligand | Optical Density (A.U) | Absorption Max (nm) | NPs/mL | Unit Size |
| GFC-3K-5 | 5 | Carboxyl | 50 OD | 515-520 | 2.73E+15 | 0.5, 1 mL |
| GFC-3K-10 | 10 | Carboxyl | 50 OD | 520 | 2.99E+14 | 0.5, 1 mL |
| GFC-3K-15 | 15 | Carboxyl | 50 OD | 520 | 8.19E+13 | 0.5, 1 mL |
| GFC-3K-20 | 20 | Carboxyl | 50 OD | 524 | 3.27E+13 | 0.5, 1 mL |
| GFC-3K-30 | 30 | Carboxyl | 50 OD | 526 | 8.96E+12 | 0.5, 1 mL |
| GFC-3K-40 | 40 | Carboxyl | 50 OD | 530 | 3.58E+12 | 0.5, 1 mL |
| GFC-3K-50 | 50 | Carboxyl | 50 OD | 535 | 1.76E+12 | 0.5, 1 mL |
| GFC-3K-60 | 60 | Carboxyl | 50 OD | 540 | 9.8E+11 | 0.5, 1 mL |
| GFC-3K-70 | 70 | Carboxyl | 50 OD | 548 | 6.0E+11 | 0.5, 1 mL |
| GFC-3K-80 | 80 | Carboxyl | 50 OD | 553 | 3.91E+11 | 0.5, 1 mL |
| GFC-3K-90 | 90 | Carboxyl | 50 OD | 564 | 2.69E+11 | 0.5, 1 mL |
| GFC-3K-100 | 100 | Carboxyl | 50 OD | 572 | 1.92E+11 | 0.5, 1 mL |
| GFC-5K-5 | 5 | Carboxyl | 50 OD | 515-520 | 2.73E+15 | 0.5, 1 mL |
| GFC-5K-10 | 10 | Carboxyl | 50 OD | 520 | 2.99E+14 | 0.5, 1 mL |
| GFC-5K-15 | 15 | Carboxyl | 50 OD | 520 | 8.19E+13 | 0.5, 1 mL |
| GFC-5K-20 | 20 | Carboxyl | 50 OD | 524 | 3.27E+13 | 0.5, 1 mL |
| GFC-5K-30 | 30 | Carboxyl | 50 OD | 526 | 8.96E+12 | 0.5, 1 mL |
| GFC-5K-40 | 40 | Carboxyl | 50 OD | 530 | 3.58E+12 | 0.5, 1 mL |
| GFC-5K-50 | 50 | Carboxyl | 50 OD | 535 | 1.76E+12 | 0.5, 1 mL |
| GFC-5K-60 | 60 | Carboxyl | 50 OD | 540 | 9.8E+11 | 0.5, 1 mL |
| GFC-5K-70 | 70 | Carboxyl | 50 OD | 548 | 6.0E+11 | 0.5, 1 mL |
| GFC-5K-80 | 80 | Carboxyl | 50 OD | 553 | 3.91E+11 | 0.5, 1 mL |
| GFC-5K-90 | 90 | Carboxyl | 50 OD | 564 | 2.69E+11 | 0.5, 1 mL |
| GFC-5K-100 | 100 | Carboxyl | 50 OD | 572 | 1.92E+11 | 0.5, 1 mL |
Amine-PEG Linker Gold Nanoparticles
| Cat# | Diameter (nm) | Ligand | Optical Density (A.U) | Absorption Max (nm) | NPs/mL | Unit Size |
| GFA-3K-5 | 5 | Amine | 50 OD | 515-520 | 2.73E+15 | 0.5, 1 mL |
| GFA-3K-10 | 10 | Amine | 50 OD | 520 | 2.99E+14 | 0.5, 1 mL |
| GFA-3K-15 | 15 | Amine | 50 OD | 520 | 8.19E+13 | 0.5, 1 mL |
| GFA-3K-20 | 20 | Amine | 50 OD | 524 | 3.27E+13 | 0.5, 1 mL |
| GFA-3K-30 | 30 | Amine | 50 OD | 526 | 8.96E+12 | 0.5, 1 mL |
| GFA-3K-40 | 40 | Amine | 50 OD | 530 | 3.58E+12 | 0.5, 1 mL |
| GFA-3K-50 | 50 | Amine | 50 OD | 535 | 1.76E+12 | 0.5, 1 mL |
| GFA-3K-60 | 60 | Amine | 50 OD | 540 | 9.8E+11 | 0.5, 1 mL |
| GFA-3K-70 | 70 | Amine | 50 OD | 548 | 6.0E+11 | 0.5, 1 mL |
| GFA-3K-80 | 80 | Amine | 50 OD | 553 | 3.91E+11 | 0.5, 1 mL |
| GFA-3K-90 | 90 | Amine | 50 OD | 564 | 2.69E+11 | 0.5, 1 mL |
| GFA-3K-100 | 100 | Amine | 50 OD | 572 | 1.92E+11 | 0.5, 1 mL |
| GFA-5K-5 | 5 | Amine | 50 OD | 515-520 | 2.73E+15 | 0.5, 1 mL |
| GFA-5K-10 | 10 | Amine | 50 OD | 520 | 2.99E+14 | 0.5, 1 mL |
| GFA-5K-15 | 15 | Amine | 50 OD | 520 | 8.19E+13 | 0.5, 1 mL |
| GFA-5K-20 | 20 | Amine | 50 OD | 524 | 3.27E+13 | 0.5, 1 mL |
| GFA-5K-30 | 30 | Amine | 50 OD | 526 | 8.96E+12 | 0.5, 1 mL |
| GFA-5K-40 | 40 | Amine | 50 OD | 530 | 3.58E+12 | 0.5, 1 mL |
| GFA-5K-50 | 50 | Amine | 50 OD | 535 | 1.76E+12 | 0.5, 1 mL |
| GFA-5K-60 | 60 | Amine | 50 OD | 540 | 9.8E+11 | 0.5, 1 mL |
| GFA-5K-70 | 70 | Amine | 50 OD | 548 | 6.0E+11 | 0.5, 1 mL |
| GFA-5K-80 | 80 | Amine | 50 OD | 553 | 3.91E+11 | 0.5, 1 mL |
| GFA-5K-90 | 90 | Amine | 50 OD | 564 | 2.69E+11 | 0.5, 1 mL |
| GFA-5K-100 | 100 | Amine | 50 OD | 572 | 1.92E+11 | 0.5, 1 mL |
安必奇可提供的金納米球包括但不限于上述產品，其他規格可根據客戶要求定制，同時可提供抗體偶聯定制服務。我們的科研團隊，竭誠為您服務。
